Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - amantadini hydrochloridum - kapseln - amantadini hydrochloridum 100 mg, rapae oleum raffinatum, lecithinum ex soja, sojae oleum partim hydrogenatum 10.67 mg, cera flava, sojae oleum hydrogenatum 2.67 mg, kapselhülle: e 215 0.53 mg, gelatina, glycerolum (85 per centum), e 172 (rubrum), propylis parahydroxybenzoas natricus 0.27 mg, sorbitolum 6.738 mg, mannitolum, amylum hydrolysatum, e 171, drucktinte: lacca, e 171 pro capsula corresp. natrium 0.72 mg. - morbus parkinson, grippeprophylaxe - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - kalii chloridum - dragees - kalii chloridum 600 mg endwerte. 8 mmol, excipiens pro compresso dunst. - kaliumpräparat - synthetik menschlichen

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - baclofenum - tabletten - baclofenum 10.0 mg, tritici amylum 61.0 mg, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, povidonum k 30, pro compresso. - myotonolyticum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - baclofenum - tabletten - baclofenum 25.0 mg, tritici amylum 83.0 mg, cellulosum microcristallinum, povidonum k 30, silica colloidalis anhydrica, magnesii stearas, pro compresso. - myotonolyticum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - carbamazepinum - suspension zum einnehmen - carbamazepinum 100 mg, macrogoli 8 stearas typus i, hydroxyethylcellulosum, cellulosum microcristallinum, carmellosum natricum, sorbitolum liquidum non cristallisabile 1.25 g, propylenglycolum 125 mg, aqua purificata, aromatica (caramel), saccharinum natricum, e 200, propylis parahydroxybenzoas 1.5 mg, e 218 6 mg ad suspensionem pro 5 ml corresp. natrium 0.57 mg. - antiepilepticum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - diclofenacum natricum - dragees - diclofenacum natricum 25 mg, silica colloidalis anhydrica, cellulosum microcristallinum, lactosum monohydricum 16 mg, magnesii stearas, maydis amylum, povidonum k 30, carboxymethylamylum natricum a, Überzug: hypromellosum, macrogolglyceroli hydroxystearas 130 µg, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, macrogolum 8000, simeticonum, e 171, e 172 (flavum), pro compresso obducto corresp. natrium 2.36 mg. - antirheumaticum, antiphlogisticum, analgeticum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - diclofenacum natricum - dragees - diclofenacum natricum 50 mg, silica colloidalis anhydrica, cellulosum microcristallinum, lactosum monohydricum 25 mg, magnesii stearas, maydis amylum, povidonum k 30, carboxymethylamylum natricum a, Überzug: hypromellosum, macrogolglyceroli hydroxystearas 220 µg, talcum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, macrogolum 8000, simeticonum, e 171, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 4.16 mg. - antirheumaticum, antiphlogisticum, analgeticum - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - kapseln - levodopum 50.00 mg, benserazidum 12.50 mg ut benserazidi hydrochloridum, mannitolum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (nigrum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbus parkinson, restless-legs-syndrom - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - kapseln - levodopum 100.0 mg, benserazidum 25.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (rubrum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbus parkinson, restless-legs-syndrom - synthetika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

roche pharma (schweiz) ag - levodopum, benserazidum - kapseln - levodopum 200.0 mg, benserazidum 50.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum k 90, magnesii stearas, kapselhülle: e 172 (rubrum), e 172 (flavum), e 171, e 132, gelatina, drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, e 172 (nigrum), pro capsula. - morbus parkinson, restless-legs-syndrom - synthetika